Very Rare Cancer Consortium Tumor Board Meeting

Please join us for the Very Rare Cancer Consortium Tumor Board Meeting. This new initiative aims to bring cancer researchers across New York to the table to discuss compelling rare cancer cases presented by physicians and scientists from the New York Genome Center’s partner institutions. Click here to learn more about the Very Rare Cancer Consortium.

WHEN:
Thursday, January 21, 2021
4pm – 6pm

HEME MALIGNANCIES

Case Conference 

This will be a VIRTUAL meeting via Zoom.
Please note registration is required.

SPEAKERS

Jing Chen, MD Pediatric Hematology-Oncology Hackensack Meridian Health Hackensack University Medical Center “Relapsed AML with NUP98-KDM5A Fusion”

Mahmut Yaser Çeliker, MD Pediatric Hematology & Medical Oncology Maimonides Children’s Hospital “Use of FLT3 Inhibitors in 16-Year-Old with AML“

Elli Papaemmanuil, PhD Assistant Attending, Computational Oncology Memorial Sloan Kettering Cancer Center “Utility of Low-Pass Whole-Genome Sequencing for Peds Leukemia”   (Copresented with Jesus Gutierrez-Abril, PhD)

Jesus Gutierrez-Abril, PhD Research Fellow, Elli Papaemmanuil Laboratory Memorial Sloan Kettering Cancer Center

Christopher J. Forlenza, MD Pediatric Hematology-Oncology Memorial Sloan Kettering Cancer Center  “Atypical Lymphomatous Relapse of T-ALL”

Alycia Foti, MD Fellow Division of Pediatric Hematology/Oncology/Stem Cell Transplantation Columbia Irving Medical Center   “ALK+ Large B-Cell Lymphoma”

Any questions on this event, contact events@nygenome.org.